Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greenberg

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The New England Journal of Medicine|January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent feverThomas J Walsh, Peter Pappas, Drew J Winston, et al.
JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
JAMA Pediatrics|February 19, 2019
A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial InfectionsNathan Kuppermann, Peter S Dayan, Deborah A Levine, et al.
JAMA|August 24, 2016
Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or YoungerPrashant Mahajan, Nathan Kuppermann, Asuncion Mejias, et al.
Pediatrics|September 13, 2022
Serious Bacterial Infections in Young Febrile Infants With Positive Urinalysis ResultsPrashant Mahajan, John M VanBuren, Leah Tzimenatos, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The New England Journal of Medicine|January 25, 2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent feverThomas J Walsh, Peter Pappas, Drew J Winston, et al.
JAMA Network Open|November 16, 2022
Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality TherapyAnthony M Magliocco, Jennifer Moughan, David T Miyamoto, et al.
JAMA Pediatrics|February 19, 2019
A Clinical Prediction Rule to Identify Febrile Infants 60 Days and Younger at Low Risk for Serious Bacterial InfectionsNathan Kuppermann, Peter S Dayan, Deborah A Levine, et al.
JAMA|August 24, 2016
Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or YoungerPrashant Mahajan, Nathan Kuppermann, Asuncion Mejias, et al.
Pediatrics|September 13, 2022
Serious Bacterial Infections in Young Febrile Infants With Positive Urinalysis ResultsPrashant Mahajan, John M VanBuren, Leah Tzimenatos, et al.
Pageof 3